Grown Rogue International Inc (GRUSF) stock news · rev $32.4M
Grown Rogue International Inc (GRUSF) is a drug manufacturers - specialty & generic company listed on US.
This GRUSF news page leads with what Grown Rogue International Inc filed — not a scraped headline mill.
No cached 8-K sentence for GRUSF yet. We will not pad this page with generic market recap.
Latest reported GRUSF revenue for 2025-12-31 was $32.4M. Net income was $3.2M. Revenue was up 21.8% from 2024-12-31 to 2025-12-31. GRUSF currently screens at market cap $107.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the GRUSF stock page; for the tape open the quote page.
Not investment advice.